Egbert Smit
Overview
Explore the profile of Egbert Smit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
2933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Derks J, van Suylen R, Thunnissen E, den Bakker M, Groen H, Smit E, et al.
Eur Respir J
. 2017 Oct;
50(4).
PMID: 29074548
No abstract available.
12.
Moro-Sibilot D, Smit E, de Castro Carpeno J, Lesniewski-Kmak K, Aerts J, Villatoro R, et al.
Lung Cancer
. 2016 Jan;
90(3):427-32.
PMID: 26791802
Objectives: We report on a post-hoc analysis of patients with brain metastases from a large prospective observational study of first-line treatment of non-small cell lung cancer (NSCLC). The aim was...
13.
Smit E, Moro-Sibilot D, de Castro Carpeno J, Lesniewski-Kmak K, Aerts J, Villatoro R, et al.
Lung Cancer
. 2016 Jan;
92:35-40.
PMID: 26775594
Objectives: To explore patient and disease factors, and reasons behind the physician's choice of platinum backbone for the first-line treatment of non-small cell lung cancer (NSCLC), as observed in a...
14.
Abdelraouf F, Smit E, Hasan B, Menis J, Popat S, van Meerbeeck J, et al.
Eur J Cancer
. 2015 Dec;
54:35-39.
PMID: 26716400
Background: Targeted therapies have to date not been successful in the treatment of small cell lung cancer (SCLC). This study aimed to assess the therapeutic activity of sunitinib (an oral,...
15.
Moro-Sibilot D, Smit E, de Castro Carpeno J, Lesniewski-Kmak K, Aerts J, Villatoro R, et al.
Lung Cancer
. 2015 Mar;
88(2):215-22.
PMID: 25748103
Introduction: FRAME was a prospective observational study that captured real-world data on patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving platinum-based chemotherapies as first-line treatment (FLT) across...
16.
17.
Peters S, Weder W, Dafni U, Kerr K, Bubendorf L, Meldgaard P, et al.
J Thorac Oncol
. 2014 Dec;
9(11):1675-84.
PMID: 25436801
Introduction: The Lungscape project was designed to address the impact of clinical, pathological, and molecular characteristics on outcome in resected non-small- cell lung cancer (NSCLC). Materials And Methods: A decentralized...
18.
19.
Gautschi O, Dingemans A, Crowe S, Peters S, Roder H, Grigorieva J, et al.
Lung Cancer
. 2012 Nov;
79(1):59-64.
PMID: 23122759
Background: VeriStrat(®) is a serum proteomic test used to determine whether patients with advanced non-small cell lung cancer (NSCLC) who have already received chemotherapy are likely to have good or...
20.
Schnabel P, Smit E, de Castro Carpeno J, Lesniewski-Kmak K, Aerts J, Kraaij K, et al.
Lung Cancer
. 2012 Oct;
78(3):263-9.
PMID: 23040326
FRAME is a prospective observational study of first-line treatments for advanced non-small cell lung cancer (NSCLC). This interim analysis examines the influence of histology and biomarkers on therapeutic decisions. Baseline...